Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 30,000 shares at $29.14 ($878K) on 2015-12-01, disclosed to the SEC on 2015-12-02.
Scheduled sale ($878k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.14 | 20,374 | $594K | 67.6% |
| 2 | $29.43 | 3,249 | $96K | 10.9% |
| 3 | $29.45 | 3,987 | $117K | 13.4% |
| 4 | $29.81 | 1,890 | $56K | 6.4% |
| 5 | $30.06 | 100 | $3K | 0.3% |
| 6 | $30.06 | 400 |
| $12K |
| 1.4% |
| Total | $29.27 avg | 30,000 | $878K | 100% |
| Filing → |
| ADRO | SELL | 2017-07-06 | $567K | — | Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |